CTSA K12 Program at Harvard Medical School

哈佛医学院 CTSA K12 项目

• 批准号: 10621595
• 负责人: Karen K Miller
• 金额: $ 161.98万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-15 至 2028-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10621595
• 关键词: Academic Medical Centers; Academy; Clinical; Clinical Investigator; Clinical Research; Clinical Sciences; Communities; Competence; Dedications; Development; Educational Curriculum; Elements; Ensure; Environment; Funding; Future; Goals; Growth; Health; Human; Infrastructure; Leadership; Medical Research; Mentored Clinical Scientist Development Program; Mentors; Mentorship; National Center for Advancing Translational Sciences; Performance; Program Development; Research; Research Personnel; Scholars Program; Science; Time; Training; Translating; Translational Research; United States National Institutes of Health; Work; career; career development; catalyst; community engagement; diversity and inclusion; educational atmosphere; improved; innovation; interdisciplinary collaboration; medical schools; programs; success; translational pipeline; translational scientist; visiting scholar; Academic Medical Centers; Academy; Clinical; Clinical Investigator; Clinical Research; Clinical Sciences; Communities; Competence; Dedications; Development; Educational Curriculum; Elements; Ensure; Environment; Funding; Future; Goals; Growth; Health; Human; Infrastructure; Leadership; Medical Research; Mentored Clinical Scientist Development Program; Mentors; Mentorship; National Center for Advancing Translational Sciences; Performance; Program Development; Research; Research Personnel; Scholars Program; Science; Time; Training; Translating; Translational Research; United States National Institutes of Health; Work; career; career development; catalyst; community engagement; diversity and inclusion; educational atmosphere; improved; innovation; interdisciplinary collaboration; medical schools; programs; success; translational pipeline; translational scientist; visiting scholar

PROJECT SUMMARY The goal of the Harvard Catalyst K12 program is to create an environment for early-stage clinical and translational (CT) investigators that facilitates their career development and encourages paradigm-shifting, diversity-focused interdisciplinary collaboration and team-based research approaches to advance CT science. Since its founding in 2008, the Harvard Catalyst KL2 program has served as the cornerstone across Harvard Medical School (HMS) and its affiliated academic medical centers for training our most outstanding early-stage CT investigators. Given the demonstrated success of the KL2 program since 2008, the new K12 program will build on the KL2 program's strengths. The new K12 program will specifically seek to help train and develop the future leaders of CT science by leveraging the Harvard Catalyst cores and integrating the scholars into the broader CT infrastructure at Harvard Catalyst and the CTSA consortium. In addition, through dedicated funding from the HMS-affiliated AMCs, the K12 program will continue to be paired with the Catalyst Medical Research Investigator (CMeRIT) program to further enrich the K12 learning environment. Moreover, through the continued growth and expansion of the Clinical and Translational Research Academy, a supporting infrastructural element of Harvard Catalyst, the K12 will create a community for CT investigators and enhance the transition to independence for all K awardees across HMS. Finally, the K12 program will work closely with the Harvard Catalyst Cores and other NIH-funded programs at HMS to enhance the research capability, competency and performance of all K12 awardees with a new focus on translational science. The overarching objective of the program is to ensure and nurture the sustainable careers of early-stage CT investigators and ultimately advance translational science. The K12 program will offer sustained protected time for scholars to advance their CT research, overseen by a primary mentor and co-mentor and now further enhanced by a dedicated mentorship committee, including a separate career mentor to provide outside input on broader career goals. Training will include the use of new courses and programs, including our monthly Translate Together curriculum, that covers the broad translational spectrum and focuses on developing innovative solutions that improve human health. It will also include the development of individualized career development programs, leadership training, visibility through participation in the national CTSA Visiting Scholar Program, and mentor/mentee training, to ensure the success of each scholar as a translational scientist as envisioned by NCATS. The K12 will also seek to educate scholars on the importance of community engagement for the execution of effective CT research to ensure the highest quality science can be completed. In a related context, building on our earlier success in improving the diversity of the KL2 program, we will continue several diversity and inclusion initiatives both to ensure that we have a vibrant and diverse group of scholars but also to ensure that all scholars are fully educated on diversity as a critical feature of all successful CT research endeavors.

项目摘要 哈佛大学催化剂K12计划的目标是为早期临床和 促进其职业发展并鼓励范式转移的转化（CT）调查员 以多样性为中心的跨学科合作和基于团队的研究方法来推进CT科学。 自2008年成立以来，哈佛大学催化剂KL2计划一直是哈佛的基石 医学院（HMS）及其附属学术医疗中心，用于培训我们最杰出的早期阶段 CT调查人员。鉴于自2008年以来，KL2计划取得了成功，新的K12计划将 基于KL2计划的优势。新的K12计划将特别寻求帮助培训和开发 通过利用哈佛大学催化剂核心并将学者融入到CT科学的未来领导者 哈佛大学催化剂和CTSA财团的CT基础设施更广泛。此外，通过专门的资金 从HMS相关的AMC中，K12计划将继续与Catalyst Medical Research配对 研究人员（CMEIT）计划，以进一步丰富K12学习环境。而且，通过 临床和转化研究学院的增长和扩展，支持基础设施 哈佛催化剂的元素，K12将为CT调查人员创建一个社区，并增强过渡 独立于HMS的所有K获奖者。最后，K12计划将与哈佛紧密合作 HMS的催化剂核心和其他NIH资助的计划，以增强研究能力，能力和 所有K12获奖者的表现都以新的转化科学为重点。总体目标 计划旨在确保和培养早期CT调查人员的可持续职业，并最终进步 翻译科学。 K12计划将为学者提供持续的保护时间 研究，由主要导师兼副主管监督，现在由专门的指导进一步增强 委员会，包括一位单独的职业导师，以提供有关更广泛职业目标的外部意见。培训意志 包括使用新课程和课程的使用，包括我们每月翻译的课程，涵盖 广泛的转化范围并着重于开发改善人类健康的创新解决方案。它 还将包括开发个性化职业发展计划，领导培训，可见性 通过参加国家CTSA访问学者计划和导师/导师培训，以确保 NCAT所设想的每个学者作为转化科学家的成功。 K12也将寻求教育 学者介绍社区参与对执行有效CT研究的重要性，以确保 最高质量的科学可以完成。在相关背景下，基于我们早期成功改善的成功 KL2计划的多样性，我们将继续进行多种多样性和包容性计划，以确保我们 拥有一个充满活力和多样化的学者，同时也要确保所有学者都对多样性进行全面教育 作为所有成功的CT研究努力的关键特征。